Roberta Cariati Selected Research

mofarotene

2/2003

Inhibition of oxidative phosphorylation underlies the antiproliferative and proapoptotic effects of mofarotene (Ro 40-8757) in Burkitt's lymphoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberta Cariati Research Topics

Disease

4	Gaucher Disease (Gaucher's Disease) 04/2014 - 01/2005
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2005
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2005
1	Glycogen Storage Disease Type II (Pompe's Disease) 03/2004
1	Fabry Disease (Fabry's Disease) 01/2004
1	Lymphoma (Lymphomas) 02/2003
1	Burkitt Lymphoma (Burkitt's Lymphoma) 02/2003

Drug/Important Bio-Agent (IBA)

3	Glucosylceramidase (Glucocerebrosidase)IBA 12/2012 - 01/2005
2	AcidsIBA 04/2014 - 03/2004
2	EnzymesIBA 03/2004 - 02/2003
1	GlucosidasesIBA 04/2014
1	Interleukin-4 (Interleukin 4)IBA 01/2005
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2005
1	GlycolipidsIBA 01/2005
1	Glucosylceramides (Glucocerebrosides)IBA 01/2005
1	alpha-Glucosidases (Acid Maltase)IBA 03/2004
1	Glutamine (L-Glutamine)FDA Link 01/2004
1	SphingolipidsIBA 01/2004
1	alpha-Galactosidase (Beano)IBA 01/2004
1	Proteins (Proteins, Gene)FDA Link 01/2004
1	mofaroteneIBA 02/2003
1	RetinoidsIBA 02/2003

Therapy/Procedure

2	Enzyme Replacement Therapy 12/2012 - 01/2005
1	Therapeutics 01/2005